Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009; 39: 699-706.GuthSTheuneUAberleJGalachABambergerCMVery high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examinationEur J Clin Invest20093969970610.1111/j.1365-2362.2009.02162.x19601965Search in Google Scholar
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214.American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid CancerCooperDSDohertyGMHaugenBRRevised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancerThyroid200919116721410.1089/thy.2009.011019860577Search in Google Scholar
Ito Y, Amino N, Yokozawa T, Ota H, Ohshita M, Murata N, et al. Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid 2007; 17: 1269-76.ItoYAminoNYokozawaTOtaHOhshitaMMurataNUltrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findingsThyroid20071712697610.1089/thy.2007.001417988196Search in Google Scholar
Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36: 425-37.BalochZWLiVolsiVAAsaSLRosaiJMerinoMJRandolphGDiagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science ConferenceDiagn Cytopathol2008364253710.1002/dc.2083018478609Search in Google Scholar
National Comprehensive Cancer Network (2015) NCCN Clinical practice guidelines in oncology (NCCN Guidelines) Thyroid carcinoma. Version 2.2015. National Comprehensive Cancer Network, Washington. Available at http://www.nccn.org/professionals/physician_gls/f_guidelines. asp#thyroid. Accessed on 21 August 2015National Comprehensive Cancer Network (2015) NCCN Clinical practice guidelines in oncology (NCCN Guidelines) Thyroid carcinoma. Version 2.2015. National Comprehensive Cancer Network, WashingtonAvailable athttp://www.nccn.org/professionals/physician_gls/f_guidelines. asp#thyroidAccessed on 21 August 2015Search in Google Scholar
Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol 2012; 56: 333-9.BongiovanniMSpitaleAFaquinWCMazzucchelliLBalochZWThe Bethesda System for Reporting Thyroid Cytopathology: a meta-analysisActa Cytol201256333910.1159/00033995922846422Search in Google Scholar
Petric R, Perhavec A, Gazic B, Besic N. Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland. J Surg Oncol 2012; 105: 351-6.PetricRPerhavecAGazicBBesicNPreoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid glandJ Surg Oncol2012105351610.1002/jso.2203021751218Search in Google Scholar
Strazisar B, Petric R, Sesek M, Zgajnar J, Hocevar M, Besic N. Predictive factors of carcinoma in 279 patients with Hürthle cell neoplasm of the thyroid gland. J Surg Oncol 2010; 101: 582-6.StrazisarBPetricRSesekMZgajnarJHocevarMBesicNPredictive factors of carcinoma in 279 patients with Hürthle cell neoplasm of the thyroid glandJ Surg Oncol2010101582610.1002/jso.2152620461764Search in Google Scholar
Sobin LH, Gospodarowitz MK, Witekind C. Thyroid gland (ICD-O C73). In: Sobin LH, Gospodarowitz MK, Witekind C, editors. TNM classification of malignant tumours. 7th edition. New York: Wiley Blackwell; 2009. p. 58-62.SobinLHGospodarowitzMKWitekindCThyroid gland (ICD-O C73)SobinLHGospodarowitzMKWitekindCTNM classification of malignant tumours7th editionNew YorkWiley Blackwell2009586210.1002/9780471420194.tnmc08.pub2Search in Google Scholar
Jamsek J, Zagar I, Gaberscek S, Grmek M. Thyroid lesions incidentally detected by (18)F-FDG PET-CT - a two centre retrospective study. Radiol Oncol 2015; 49: 121-7.JamsekJZagarIGaberscekSGrmekMThyroid lesions incidentally detected by (18)F-FDG PET-CT - a two centre retrospective studyRadiol Oncol201549121710.2478/raon-2014-0039438798726029022Search in Google Scholar
Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, Shong YK. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 2004; 60: 21-8.Nam-GoongISKimHYGongGLeeHKHongSJKimWBShongYKUltrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findingsClin Endocrinol (Oxf)20046021810.1046/j.1365-2265.2003.01912.x14678283Search in Google Scholar
Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994; 18: 559-67.ScheumannGFGimmOWegenerGHundeshagenHDralleHPrognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancerWorld J Surg1994185596710.1007/BF003537657725745Search in Google Scholar
Ito Y, Miyauchi A. Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg 2008; 32: 729-39.ItoYMiyauchiALateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinomaWorld J Surg2008327293910.1007/s00268-007-9315-918064515Search in Google Scholar
Stulak JM, Grant CS, Farley DR, Thompson GB, van Heerden JA, Hay ID, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006; 141: 489-94.StulakJMGrantCSFarleyDRThompsonGBvan HeerdenJAHayIDValue of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancerArch Surg20061414899410.1001/archsurg.141.5.48916702521Search in Google Scholar
O’Connell K, Yen TW, Quiroz F, Evans DB, Wang TS. The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer. Surgery 2013; 154: 697-701.O’ConnellKYenTWQuirozFEvansDBWangTSThe utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancerSurgery201315469770110.1016/j.surg.2013.06.04024011674Search in Google Scholar
Paunovic I, Krgovic K, Tatic S, Diklic A, Zivaljevic V, Kalezic N, Havelka M. Surgery for thyroid Hürthle cell tumours – a single institution experience. Eur J Surg Oncol 2006; 32: 458-61.PaunovicIKrgovicKTaticSDiklicAZivaljevicVKalezicNHavelkaMSurgery for thyroid Hürthle cell tumours – a single institution experienceEur J Surg Oncol2006324586110.1016/j.ejso.2005.11.02316497473Search in Google Scholar
Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010; 20: 1341-9.TuttleRMTalaHShahJLeboeufRGhosseinRGonenMEstimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging systemThyroid2010201341910.1089/thy.2010.0178484567421034228Search in Google Scholar
Roti E, degli Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol; 159: 659-73.RotiEdegli UbertiECBondanelliMBravermanLEThyroid papillary microcarcinoma: a descriptive and meta-analysis studyEur J Endocrinol1596597310.1530/EJE-07-089618713843Search in Google Scholar
Besic N, Pilko G, Petric R, Hocevar M, Zgajnar J. (2008) Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol 2008; 97: 221-5.BesicNPilkoGPetricRHocevarMZgajnarJ(2008) Papillary thyroid microcarcinoma: prognostic factors and treatmentJ Surg Oncol200897221510.1002/jso.2093518050283Search in Google Scholar
Ito Y, Kudo T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A. Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors. Endocr J 2012; 59: 119-25.ItoYKudoTKiharaMTakamuraYKobayashiKMiyaAMiyauchiAPrognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumorsEndocr J2012591192510.1507/endocrj.EJ11-028822068114Search in Google Scholar
Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999; 9: 421-7.MazzaferriELAn overview of the management of papillary and follicular thyroid carcinomaThyroid19999421710.1089/thy.1999.9.42110365671Search in Google Scholar
Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002; 26: 879-85.HayIDThompsonGBGrantCSBergstralhEJDvorakCEGormanCAPapillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patientsWorld J Surg2002268798510.1007/s00268-002-6612-1Search in Google Scholar
Khafif A, Khafif RA, Attie JN. Hurthle cell carcinoma: a malignancy of low-grade potential. Head Neck 1999; 21: 506-11.KhafifAKhafifRAAttieJNHurthle cell carcinoma: a malignancy of low-grade potentialHead Neck1999215061110.1002/(SICI)1097-0347(199909)21:6<506::AID-HED2>3.0.CO;2-MSearch in Google Scholar
Stojadinovic A, Hoos A, Ghossein RA, Urist MJ, Leung DH, Spiro RH, et al. Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol 2002; 9: 197-203.StojadinovicAHoosAGhosseinRAUristMJLeungDHSpiroRHHürthle cell carcinoma: a 60-year experienceAnn Surg Oncol20029197203Search in Google Scholar
Mills SC, Haq M, Smellie WJ, Harmer C. Hurthle cell carcinoma of the thyroid: retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol 2009; 35: 230-4.MillsSCHaqMSmellieWJHarmerCHurthle cell carcinoma of the thyroid: retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003Eur J Surg Oncol200935230410.1016/j.ejso.2008.06.007Search in Google Scholar
Petric R, Gazic B, Besic N. Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience. BMC Cancer 2014; 14: 777.PetricRGazicBBesicNPrognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experienceBMC Cancer20141477710.1186/1471-2407-14-777Search in Google Scholar
